gila monster venom glp 1 Ozempic Literally Came From a – And It's Not Alone : ScienceAlert Venom Helped Create Weight-Loss Drugs.

Chronic dosing amplifies rare signals

04, 2026 (GLOBE NEWSWIRE) -- Noom, the leading behavior change company, today shared new real-world findings from tens of thousands of members, showing a clear relationship: members who engage more with Noom's leading GLP-1 Companion app tend to lose more weight and stay on a medication program longer

Farkas I, Vastagh C, Farkas E, et al

Agents such as sitagliptin and saxagliptin are available for first-line or adjunctive therapy

This could potentially simplify manufacturing and distribution while offering patients another oral treatment option

A phase I/II trial of dapagliflozin in 38 lupus patients (including with and without lupus nephritis) showed an acceptable safety profile, with no increase in disease activity or proteinuria over the 6 months of the study